Literature DB >> 27493324

Time to switch from quinine.

Ahmed Awad Adeel1.   

Abstract

Entities:  

Year:  2012        PMID： 27493324      PMCID： PMC4949820     

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN： 0256-4408


× No keyword cloud information.
  7 in total

Review 1.  WHO, the Global Fund, and medical malpractice in malaria treatment.

Authors:  Amir Attaran; Karen I Barnes; Christopher Curtis; Umberto d'Alessandro; Caterina I Fanello; Mary R Galinski; Gilbert Kokwaro; Sornchai Looareesuwan; Michael Makanga; Theonest K Mutabingwa; Ambrose Talisuna; Jean François Trape; William M Watkins
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

2.  International ethical guidelines for biomedical research involving human subjects.

Authors: 
Journal:  Bull Med Ethics       Date:  2002-10

Review 3.  Artesunate versus quinine for treating severe malaria.

Authors:  David Sinclair; Sarah Donegan; David G Lalloo
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

4.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Authors:  Arjen Dondorp; François Nosten; Kasia Stepniewska; Nick Day; Nick White
Journal:  Lancet       Date:  2005 Aug 27-Sep 2       Impact factor: 79.321

5.  The efficacy of artemether versus quinine in the treatment of cerebral malaria.

Authors:  Gwiria M H Satti; Sarrar Hamza Elhassan; Salah A Ibrahim
Journal:  J Egypt Soc Parasitol       Date:  2002-08

6.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

7.  From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

Authors:  E M Malik; T A Mohamed; K A Elmardi; R M Mowien; A H Elhassan; S B Elamin; A A Mannan; E S Ahmed
Journal:  Malar J       Date:  2006-07-31       Impact factor: 2.979
  7 in total
  1 in total

1.  Artesunate Affects T Antigen Expression and Survival of Virus-Positive Merkel Cell Carcinoma.

Authors:  Bhavishya Sarma; Christoph Willmes; Laura Angerer; Christian Adam; Jürgen C Becker; Thibault Kervarrec; David Schrama; Roland Houben
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.